Starting highly active antiretroviral therapy: why, when and response to HAART
A Mocroft, JD Lundgren - Journal of Antimicrobial …, 2004 - academic.oup.com
Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
Starting highly active antiretroviral therapy: why, when and response to HAART
A Mocroft, JD Lundgren - The Journal of antimicrobial …, 2004 - research.regionh.dk
Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
[PDF][PDF] Starting highly active antiretroviral therapy: why, when and response to HAART
A Mocroft, JD Lundgren - Journal of Antimicrobial Chemotherapy, 2004 - Citeseer
Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
[引用][C] Starting highly active antiretroviral therapy: why, when and response to HAART
A MOCROFT, JD LUNDGREN - Journal of antimicrobial …, 2004 - pascal-francis.inist.fr
Starting highly active antiretroviral therapy: why, when and response to HAART CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Starting highly active antiretroviral therapy: why, when and response to HAART
A Mocroft, JD Lundgren - The Journal of antimicrobial …, 2004 - pubmed.ncbi.nlm.nih.gov
Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
Starting highly active antiretroviral therapy: why, when and response to HAART
A Mocroft, JD Lundgren - Journal of Antimicrobial Chemotherapy, 2004 - elibrary.ru
Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
Starting highly active antiretroviral therapy: why, when and response to HAART.
A Mocroft, JD Lundgren - The Journal of Antimicrobial …, 2004 - europepmc.org
Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …
[引用][C] Starting antiretroviral therapy: why, when and response to HAART
A Mocroft, JD Lundgren - Journal of Antimicrobial …, 2004 - research.regionh.dk
Starting antiretroviral therapy: why, when and response to HAART [review]. — The Capital
Region of Denmark's Research Portal Skip to main navigation Skip to search Skip to main …
Region of Denmark's Research Portal Skip to main navigation Skip to search Skip to main …